Jane Street Group, LLC Coherus Bio Sciences, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 67,606 shares of CHRS stock, worth $93,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,606
Previous 208,473 67.57%
Holding current value
$93,972
Previous $360,000 80.56%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.99 - $1.8 $139,458 - $253,560
-140,867 Reduced 67.57%
67,606 $70,000
Q2 2024

Aug 14, 2024
SELL
$1.58 - $2.51 $241,880 - $384,253
-153,089 Reduced 42.34%
208,473 $360,000
Q1 2024

May 15, 2024
SELL
$2.02 - $3.14 $388,514 - $603,928
-192,334 Reduced 34.72%
361,562 $864,000
Q4 2023

Feb 14, 2024
BUY
$1.59 - $3.85 $501,260 - $1.21 Million
315,258 Added 132.11%
553,896 $1.84 Million
Q3 2023

Nov 14, 2023
SELL
$3.74 - $5.45 $931,241 - $1.36 Million
-248,995 Reduced 51.06%
238,638 $892,000
Q2 2023

Aug 14, 2023
BUY
$3.79 - $8.3 $1.44 Million - $3.16 Million
380,692 Added 355.98%
487,633 $2.08 Million
Q1 2023

May 15, 2023
BUY
$5.89 - $10.52 $552,069 - $986,039
93,730 Added 709.48%
106,941 $731,000
Q4 2022

Feb 14, 2023
SELL
$5.69 - $10.07 $60,291 - $106,701
-10,596 Reduced 44.51%
13,211 $104,000
Q3 2022

Nov 14, 2022
SELL
$7.17 - $13.87 $458,894 - $887,707
-64,002 Reduced 72.89%
23,807 $229,000
Q2 2022

Aug 16, 2022
BUY
$5.86 - $13.23 $207,567 - $468,619
35,421 Added 67.61%
87,809 $635,000
Q1 2022

May 17, 2022
BUY
$10.92 - $16.41 $390,739 - $587,182
35,782 Added 215.48%
52,388 $677,000
Q4 2021

Feb 15, 2022
SELL
$15.81 - $18.99 $312,785 - $375,698
-19,784 Reduced 54.37%
16,606 $265,000
Q3 2021

Nov 16, 2021
SELL
$12.68 - $17.79 $123,947 - $173,897
-9,775 Reduced 21.17%
36,390 $585,000
Q2 2021

Aug 16, 2021
BUY
$12.95 - $15.41 $281,597 - $335,090
21,745 Added 89.05%
46,165 $639,000
Q1 2021

May 18, 2021
SELL
$14.42 - $21.39 $364,249 - $540,311
-25,260 Reduced 50.85%
24,420 $356,000
Q4 2020

Feb 17, 2021
BUY
$16.56 - $18.94 $55,343 - $63,297
3,342 Added 7.21%
49,680 $863,000
Q3 2020

Nov 17, 2020
BUY
$17.41 - $19.89 $806,744 - $921,662
46,338 New
46,338 $850,000
Q1 2020

May 15, 2020
SELL
$11.67 - $22.53 $147,870 - $285,477
-12,671 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$16.33 - $21.37 $28,103 - $36,777
1,721 Added 15.72%
12,671 $228,000
Q3 2019

Nov 14, 2019
SELL
$16.3 - $23.37 $134,295 - $192,545
-8,239 Reduced 42.94%
10,950 $222,000
Q2 2019

Aug 15, 2019
BUY
$13.1 - $22.1 $251,375 - $424,076
19,189 New
19,189 $424,000

Others Institutions Holding CHRS

# of Institutions
135
Shares Held
78M
Call Options Held
40.7K
Put Options Held
50.1K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $108M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email